Online Only Articles

Predisposed genomic instability in pre-treatment bone marrow evolves to therapy-related myeloid neoplasms in malignant lymphoma

Department of Hematology, Tokyo Medical University, Tokyo, Japan
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
Department of Molecular Oncology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan;Current address: Tokyo Women's Medical University Institute for Integrated Medical Sciences (TIIMS), Tokyo, Japan
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
Department of Hematology, Tokyo Medical University, Tokyo, Japan
Department of Hematology, Tokyo Medical University, Tokyo, Japan
Department of Hematology, Tokyo Medical University, Tokyo, Japan
Department of Hematology, Tokyo Medical University, Tokyo, Japan
Department of Hematology, Tokyo Medical University, Tokyo, Japan
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan
Department of Hematology, Tokyo Medical University, Tokyo, Japan;Department of Advanced Cellular Therapy, Tokyo Medical University, Tokyo, Japan
Department of Advanced Cellular Therapy, Tokyo Medical University, Tokyo, Japan
Department of Pathology and Tumor Biology, Kyoto University, Kyoto, Japan;Institute for the Advanced Study of Human Biology (WPI-ASHBi), Kyoto University, Kyoto, Japan;Department of Medicine, Centre for Hematology and Regenerative Medicine, Karolinska Institute, Stockholm, Sweden
Department of Hematology, Tokyo Medical University, Tokyo, Japan;Department of Advanced Cellular Therapy, Tokyo Medical University, Tokyo, Japan
Vol. 105 No. 7 (2020): July, 2020 https://doi.org/10.3324/haematol.2019.229856